Directorate Change

RNS Number : 0613B
EMIS Group PLC
08 February 2022
 

 

 

8 February 2022

 

EMIS Group plc

("EMIS Group" or "the Company")

 

Directorate change

 

EMIS Group plc (AIM: EMIS.L), the  UK leader in connected healthcare software and systems, today announces that Andy McKeon will retire as the Senior Independent Non-executive Director of the Company on 28 February 2022 having completed nine years of service.

The position of Senior Independent Director will be taken up by Kevin Boyd on Andy's retirement.

Patrick De Smedt, Chair of EMIS Group, said:

"We would like to thank Andy for his valuable contribution to the Company, after serving nine years on the Board, and also as acting as Chair of the Remuneration Committee until October last year. The Board wishes Andy all the best for the future."

 

 

For further information, contact:

 

EMIS Group plc    Tel: 0330 024 1269

Andy Thorburn, CEO

Peter Southby, CFO

www.emisgroupplc.com

 

Numis Securities Limited (Nominated Adviser & Broker)  Tel: 020 7260 1000

Joshua Hughes/Simon Willis/James Black

 

MHP Communications Tel: 020 3128 8567

Reg Hoare/James Bavister                                                               emis@mhpc.com 

 

*Information for investors, including analyst consensus forecasts, can be found on the Group's website at www.emisgroupplc.com/investors .

 

 

Notes to Editors

 

EMIS Group is the UK leader in connected healthcare software and systems. Its solutions are widely used across every major UK healthcare setting. EMIS Group's aim is to join up healthcare through innovative technology, helping to deliver better health outcomes to the UK population, supporting longer and healthier lives.

 

EMIS Group has two core business segments: EMIS Health and EMIS Enterprise.

 

EMIS Health is a supplier of innovative integrated care technology to the NHS, including primary, community, acute and social care.

 

EMIS Enterprise is focussed on growth in the business-to-business technology sector within the healthcare market, including management of medicines, partner businesses, patient-facing services and analytics.

 

 

 

LEI: 213800K474ZZK76NX913

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOABKFBPNBKDCBK

Companies

EMIS Group (EMIS)
UK 100

Latest directors dealings